EKRA: More than a Year Out, Major Questions Remain Unresolved
...
Already a member? Log in here
Sales & Marketing: The Perils of Restructuring Sales Commissions for EKRA
...
Already a member? Log in here
Compliance Perspectives: How to Spot & Avoid Kickback Risks under New EKRA Law
From - Lab Compliance Advisor
A new law passed to deal with the opioid epidemic has significant ramifications for labs including but not limited to those involved in drug addiction and…
Already a member? Log in here
New Broad All-Payor Kickback Law Impacting Laboratories, Commission-based Compensation and more
By Danielle Sloane bio and Chris Climo bio
In a recent piece of federal legislation intended to address the opioid crisis across the United States, Congress enacted a new all-payor kickback law that applies to…